Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 18, 2016

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions
Pain
Interventions
DRUG

EXPAREL

EXPAREL and bupivacaine HCl

DRUG

Bupivacaine

Single dose of bupivacaine HCl 0.5%

Trial Locations (17)

10003

NYU Hospital for Joint Disease, New York

10075

Lenox Hill Hospital/Northwell Health Orthopaedic Institute, New York

21204

Orthopaedic Associates, Towson

21215

Sinai Hospital of Baltimore, Baltimore

27599

UNC Orthopaedics Chapel Hill, Chapel Hill

28207

OrthoCarolina, PA, Charlotte

30060

Pinnacle Orthopaedics & Sports, Marietta

33331

Cleveland Clinic Florida, Weston

33334

Holy Cross Hospital, Fort Lauderdale

44195

Cleveland Clinic, Cleveland

45209

Wellington Orthopaedics and Sports Medicine, Cincinnati

60190

Central DuPage Hospital, Northwestern Medicine, Winfield

75034

Baylor Medical Center, Plano Orthopedics Sports Medical & Spine Center, Frisco

78234

San Antonio Military Medical Center, Fort Sam Houston

84108

Utah University Orthopedic Center, Salt Lake City

92354

Loma Linda University, Loma Linda

94538

Institute for Joint Restoration, Fremont

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY